Electrophysiology Mapping and Ablation Devices | Market Insights | US | 2023
The US EP mapping and ablation device market will experience moderate growth through 2031 due to favorable reimbursement for ablation procedures, increasing ablation procedure volumes, and the uptake of premium-priced devices. However, the COVID-19 global pandemic had a significant impact on the US EP mapping and ablation device market, resulting in lost procedure volumes in 2020. The market recovery began in the latter half of 2021 and will continue into 2022, with pre-pandemic growth levels returned by 2024.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for EP mapping and ablation devices in the US from 2019 through 2031.
Related Medtech Insights Reports
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Latin America (Supplemental)
The Latin American EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Latin American countries, improved…
